Cell MedX Corp. (CMXC) Provides Corporate Update

Cell MedX Corp. (CMXC) Provides Corporate Update

LAS VEGAS, NV — (Marketwired) — 07/13/16 — (OTCQB: CMXC) ("Cell MedX" or the "Company"), a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes, is pleased to provide its shareholders with an update on its observational clinical trial carried out by Nutrasource Diagnostics Inc. ("NDI") as well as its research and development of the eBalance Devices.Further to the news release the Com